In children with acute respiratory viral infections, the lower respiratory tract is often involved, leading to the development of bronchial obstruction. The use of the combined preparation Ascoril Expectorant (bromhexine + salbutamol + guaifenesin), due to its combined bronchodilator and mucolytic effects, results in rapid regression of disease symptoms, prevents progression to a more severe and prolonged course, and subsequently reduces the need for antibiotic therapy. The clinical efficacy and favorable safety profile of Ascoril Expectorant allow it to be recommended as the drug of choice for children over 2 years of age with mild to moderate bronchial obstruction associated with ARVI.

bromhexine, salbutamol, guaifenesin, Ascoril

Baker J.G. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors // Br. J. Pharmacol. 2010. Vol. 160. No. 5. P. 1048–1061.

Jackson D.J., et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children // Am. J. Respir. Crit. Care Med. 2008. Vol. 178. No. 7. P. 667–672.

Kotaniemi-Syrjänen A., Vainionpää R., Reijonen T.M., Waris M., Korhonen K., Korppi M. Rhinovirus-induced wheezing in infancy – the first sign of childhood asthma? // J. Allergy Clin. Immunol. 2003. Vol. 111. No. 1. P. 66–71.

Martinez F.D. What have we learned from the Tucson Children’s Respiratory Study? // Paediatr. Respir. Rev. 2002. Vol. 3. No. 3. P. 193–197.

Midulla F., et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants // Arch. Dis. Child. 2010. Vol. 95. No. 1. P. 35–41.

Papadopoulos N.G., Gourgiotis D., Javadyan A., Bossios A., Kallergi K., Psarras S., Tsolia M.N., Kafetzis D. Does respiratory syncytial virus subtype influence the severity of acute bronchiolitis in hospitalized infants? // Respir. Med. 2004. Vol. 98. No. 9. P. 879–882.

Pala P., Bjarnason R., Sigurbergsson F., Metcalfe C., Sigurs N., Openshaw P.J. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy // Eur. Respir. J. 2002. Vol. 20. No. 2. P. 376–382.

Rusconi F., et al. Maternal complications and procedures in pregnancy and at birth and wheezing phenotypes in children // Am. J. Respir. Crit. Care Med. 2007. Vol. 175. No. 1. P. 16–21.

Sanderman R., Wempe J.B., Schokker M.C. Psychological aspects of patients with a chronic disease of the lungs // Graduate School for Health Research, Netherlands. 2007. No. 1.

Simpson A., Maniatis N., Jury F., Cakebread J.A., Lowe L.A., Holgate S.T., Woodcock A., Ollier W.E., Collins A., Custovic A., Holloway J.W., John S.L. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function // Am. J. Respir. Crit. Care Med. 2005. Vol. 172. No. 1. P. 55–60.

Smyth R.L., Fletcher J.N., Thomas H.M., Hart C.A., Openshaw P.J. Respiratory syncytial virus and wheeze // Lancet. 1999. Vol. 354. No. 9194. P. 1997–1998.

Xepapadaki P., Papadopoulos N.G. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers // Eur. Respir. J. 2010. Vol. 36. No. 2. P. 438–445.